Key stats
About TIGER GLOBAL OBESITY TREATMENT TOP2 PLUS
Expense ratio
0.45%
Home page
Inception date
Feb 29, 2024
ISIN
KR7476690003
The investment trusts constructs an index of listed companies in developed countries that generate revenue or conduct R&D related to obesity treatments, with the top two holdings by market capitalization representing 25% each and the remaining eight holdings weighted by market capitalization
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks100.23%
Health Technology100.00%
Bonds, Cash & Other−0.23%
Cash−0.23%
Stock breakdown by region
North America90.55%
Europe7.71%
Asia1.74%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history